Nishizawa H, Yamada H, Miyazaki H, Ohara M, Kaneko K, Yamakawa T, Wiener-Kronish J, Kudoh I
Yokohama City University, Department of Anesthesiology, Yokohama City University School of Medicine, Japan.
Anesthesiology. 1996 Nov;85(5):1120-8. doi: 10.1097/00000542-199611000-00021.
Acid aspiration into one lung causes contralateral lung injury and systemic organ injury; this injury is thought to be mediated by the sequestration of activated neutrophils. Recombinant human soluble complement receptor 1 (sCR1) inhibits both the classical and alternative complement pathways; this study investigated the role of the complement system in unilateral acid lung injury by measuring the effects of administering sCR1 before or immediately after acid instillation.
Anesthetized rats (n = 18 in each group) underwent tracheostomy and insertion of a cannula into the anterior segment of the left lung. Then either 0.1 ml 0.1 N hydrochloric acid (HCl group) or 0.1 ml pH 7.4 phosphate buffered-saline (PBS group) was instilled. Fifteen minutes before (pre-sCR1 group) or 15 min after (post-sCR1 group) the acid was instilled, 10 mg/kg sCR1 was administered intravenously. Four hours after the acid instillation, rats were killed. In an additional 4 rats in each group, blood and bronchoalveolar lavage fluids obtained 1 h after the instillation of either acid or PBS were analyzed for tumor necrosis factor-alpha activity.
The instillation of acid led to an increased wet-to-dry ratio of 5.2 +/- 0.1 in the acid-instilled lungs compared with their contralateral lungs (4.7 +/- 0.06). These values were greater than the values of 4.6 +/- 0.2 and 4.5 +/- 0.03 in the PBS-instilled lungs and their contralateral lungs, respectively (P < 0.05). The administration of sCR1 before or immediately after the instillation of acid did not attenuate the increase in the wet-to-dry ratio of the acid-instilled lungs. However, the small but consistent increase in the wet-to-dry ratio of the contralateral lungs was attenuated by the sCR1 infusions (P < 0.05). The instillation of acid increased the protein concentration in the bronchoalveolar lavage fluids from the injured lungs (1,000 +/- 206 micrograms/ml) compared with the protein concentration measured in the bronchoalveolar lavage fluids from their contralateral lungs (254 +/- 55 micrograms/ml). The administration of sCR1 before or immediately after the instillation of acid did not decrease the protein concentration in the bronchoalveolar lavage fluids from the acid-instilled lungs. The myeloperoxidase activity was increased in the acid-instilled lung, in their contralateral lung, and in the small intestines of the animals. The infusions of sCR1 before or immediately after the administration of acid led to significant decreases in the myeloperoxidase activities measured in the lungs and the intestines of the treated animals. Plasma tumor necrosis factor-alpha activity was only increased (2.7 +/- 1.1 U/ml) in the animals that had received acid instillations. The infusions of sCR1, administered either before or immediately after the acid instillations, significantly decreased the measured tumor necrosis factor-alpha activity in the plasma (0.5 +/- 0.6 and 1.0 +/- 0.7 U/ml, respectively).
The results suggest that the complement system plays an important role in the pathogenesis of the injury of the contralateral lung and of the small intestine after unilateral instillation of acid to the lung. Further investigation is warranted to determine the clinical utility of antiinflammatory agents in acid-induced lung injury.
一侧肺吸入酸性物质会导致对侧肺损伤及全身器官损伤;这种损伤被认为是由活化中性粒细胞的隔离介导的。重组人可溶性补体受体1(sCR1)可抑制经典和替代补体途径;本研究通过测量在滴注酸性物质之前或之后立即给予sCR1的效果,来探究补体系统在单侧酸性肺损伤中的作用。
将麻醉的大鼠(每组18只)行气管切开术,并将套管插入左肺前段。然后分别滴注0.1 ml 0.1 N盐酸(HCl组)或0.1 ml pH 7.4的磷酸盐缓冲盐水(PBS组)。在滴注酸性物质前15分钟(sCR1预处理组)或滴注后15分钟(sCR1后处理组),静脉注射10 mg/kg sCR1。在滴注酸性物质4小时后,处死大鼠。在每组另外4只大鼠中,分析在滴注酸性物质或PBS 1小时后获得的血液和支气管肺泡灌洗液中的肿瘤坏死因子-α活性。
与对侧肺相比,滴注酸性物质导致滴注侧肺的湿干比增加至5.2±0.1(对侧肺为4.7±0.06)。这些值分别大于PBS滴注侧肺及其对侧肺的4.6±0.2和4.5±0.03(P<0.05)。在滴注酸性物质之前或之后立即给予sCR1,并未减轻滴注酸性物质侧肺湿干比的增加。然而,sCR1输注减弱了对侧肺湿干比虽小但持续的增加(P<0.05)。与对侧肺支气管肺泡灌洗液中的蛋白质浓度(254±55μg/ml)相比,滴注酸性物质增加了损伤侧肺支气管肺泡灌洗液中的蛋白质浓度(1000±206μg/ml)。在滴注酸性物质之前或之后立即给予sCR1,并未降低滴注酸性物质侧肺支气管肺泡灌洗液中的蛋白质浓度。在滴注酸性物质侧肺、其对侧肺以及动物的小肠中,髓过氧化物酶活性均增加。在给予酸性物质之前或之后立即输注sCR1,导致处理动物肺和小肠中测得的髓过氧化物酶活性显著降低。仅在接受酸性物质滴注的动物中,血浆肿瘤坏死因子-α活性升高(2.7±1.1 U/ml)。在酸性物质滴注之前或之后立即输注sCR1,显著降低了血浆中测得的肿瘤坏死因子-α活性(分别为0.5±0.6和1.0±0.7 U/ml)。
结果表明,补体系统在单侧肺滴注酸性物质后对侧肺和小肠损伤的发病机制中起重要作用。有必要进一步研究以确定抗炎药物在酸性物质诱导的肺损伤中的临床应用价值。